Company: AEMD
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001683168-25-008271
Chunk: 18

Company: AETHLON MEDICAL INC
Filing Date: 2025-11-12
Form: 10-Q
Item: Item 1
Chunk 18
---
4. There were no RSUs granted during the three months ended September 30, 2025. There were no stock
option exercises during the three months ended September 30, 2025 and 2024. On September 30, 2025, our outstanding stock options had no
intrinsic value, since the closing share price on that date of $7.49 per share was below the exercise price of our outstanding stock options.

The table below summarizes nonvested stock options as of September
30, 2025 and changes during the six months ended September 30, 2025.

    Schedule of non vested stock options 

    Shares  
    Weighted Average Grant Date Fair Value 
  
    Nonvested stock options at April 1, 2025 
     76  
    $1.37 
  
    Vested 
     (41) 
    $1.37 
  
    Forfeited 
     –  

    Nonvested stock options at September 30, 2025 
     35  

The detail of the options outstanding and exercisable as of September
30, 2025 is as follows:

    Schedule of options outstanding and exercisable

    Options Outstanding

    Options Exercisable

    Exercise Prices

    Number 
Outstanding

    Weighted 
Average 
Remaining 
Life (Years)

    Weighted 
Average 
Exercise 
Price

    Number 
Outstanding

    Weighted 
Average 
Exercise 
Price

    $
    1,024.00 – 1,128.00

    507

    5.72 years

    $
    1,091.90

    472

    $
    1,089.00

    $
    2,016.00

    152

    5.26 years

    $
    2,016.00

    152

    $
    2,016.00

    659

    624

The table below summarizes restricted stock units
as of September 30, 2025 and changes during the six months ended September 30, 2025.

    Schedule of RSUs 

    Shares 
  
    Nonvested RSUs at April 1, 2025 
     – 
  
    Granted 
     7,144 
  
    Vested 
     (3,572)
  
    Tax withholding payments or tax equivalent payments for net share settlement